Diabetes framework document shows ‘progress’ among CCGs

By Editor
19th January 2018
Care planning, Commissioning

Clinical commissioning groups (CCGs) across England have made ‘steady progress’, according to a newly published document looking at performance among local diabetes services. 

The findings of the CCG Improvement and Assessment Framework (CCG IAF) has shown 86 CCGs are now rated good or outstanding, which is 26 more than the previous year.

There were no inadequate ratings issued in the 2016/17 assessment, whereas for the 2015/16 document there were 38 CCGs which received that rating.

Where year-on year-comparison is valid, the national data suggests that, across the two diabetes indicators in the CCG IAF, performance is steady.

Speaking to The Diabetes Times, an NHS spokesperson said: “These results clearly show progress has been made across the country; reducing variation in performance, and with nearly all clinical commissioning groups (CCGs) participating in the most recent audit, it gives us the most comprehensive picture yet.

“However, CCGs still have more work to do which is why it is important to highlight not only where things are going well, but where additional support may be needed and to this end an additional £42m funding has been made available to advance the day-to-day care and treatment people with diabetes receive and improve outcomes.”

To support CCG improvements in the 2017/18 financial year a large number of areas received transformation funding for four priorities, including the two measures in the IAF i.e. the proportion of people newly diagnosed with diabetes receiving structured education and the proportion of all people with diabetes meeting all three NICE treatment targets for good management of diabetes.

Additionally,the NHS England diabetes programme is funding regional diabetes network leads who are particularly focussed on helping those areas that most need to improve in the CCG IAF and have not received transformation funding.

To better reflect the quality of local diabetes services in future years, the panel consider it may be helpful for CCGs to also take into account diabetes data from other recognised sources in order to help understand the wider context of their local positions in relation to the following:

Attendance at structured education in the prevalent diabetes population (%) (source: NDA)

  • Achievement of the 3 NICE recommended treatment targets in patients with type 1 diabetes (source: NDA)
  • Indirectly standardised 3-year rate of amputations in patients with diabetes (source: Public Health England)
  • Directly standardised rate of bed-days for patients with diabetes admitted to hospital (source: Hospital Episode Statistics and NDA)
  • Multidisciplinary foot care team coverage across a CCG’s commissioning footprint and Diabetes inpatient specialist nursing service coverage across a CCG’s commissioning footprint (source: NDA – National Diabetes Footcare Audit/National Diabetes Inpatient Audit)
  • Achievement of NICE recommended treatment targets in children (source National Paediatric Diabetes Audit).

The CCG IAF provides information to healthcare organisations, professionals and patients about how their local NHS services are performing and is used by national teams to drive organisational improvement through focused support.

The diabetes panel, led by Diabetes UK’s Chris Askew, brings together people with diabetes and a wide range of professionals involved in primary, community and specialist care from different disciplines, including commissioning. It advises on the assessment methodology and provides guidance on communication to CCGs and the public. The panel does not inspect CCGs or moderate any individual ratings.

To read more about the CCG IAF data, click here.

Comments (0)

Register an account or login to comment